1. Fazaeli H, Sheikholeslami A, Ebrahimi Z, Kalhor N, Naserpour L. Comparing intra-uterine injection of mononuclear cells and platelet-rich plasma on the pregnancy rate of women with recurrent implantation failure: An RCT. Int J Reprod BioMed 2024; 22: 801-810. [
DOI:10.18502/ijrm.v22i10.17668] [
PMID] [
PMCID]
2. ESHRE Working Group on Recurrent Implantation Failure, Cimadomo D, De Los Santos MJ, Griesinger G, Lainas G, Le Clef N, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open 2023; 2023: hoad023. [
DOI:10.1093/hropen/hoad023] [
PMID] [
PMCID]
3. Yoshioka S, Fujiwara H, Nakayama T, Kosaka K, Mori T, Fujii S. Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer. Hum Reprod 2006; 21: 3290-3294. [
DOI:10.1093/humrep/del312] [
PMID]
4. Chow E, To E, Chow TKF. Conflicting evidence of intrauterine immunotherapy in recurrent implantation failure lies in the flawed non-randomized trials: A meta-analysis. International Federation of Fertility Societies (IFFS) World Congress; 2025 April 26-29, Tokyo, Japan. Japan Society for Reproductive Medicine ©2025: 1638-1680.